Early tumor shrinkage of Cetuximab and mFOLFOX6 in RAS-wild type unresectable metastatic colorectal cancer.
Phase of Trial: Phase II
Latest Information Update: 11 Apr 2019
Price : $35 *
At a glance
- Drugs Cetuximab (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Adenocarcinoma; Colorectal cancer
- Focus Therapeutic Use
- Acronyms Elite
- 08 Apr 2019 Status changed from recruiting to discontinued.
- 03 Sep 2015 Status changed from not yet recruiting to recruiting, as reported by University Hospital Medical Information Network - Japan.
- 10 Oct 2014 New trial record